NRX Pharmaceuticals's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
NRX Pharmaceuticals last closed at $2.85 (-1.38%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -4.6×. Its overall grade ranks 144 of 736 stocks in Healthcare.
About this company
NRX Pharmaceuticals last closed at $2.85 (-1.38%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 144/736
Valuation grade A-
Related stocks
- Amylyx PharmaceuticalsCompetitor
ALS 등 희귀신경계 질환 치료제 개발에서 경쟁
- BiogenCompetitor
신경계 질환 치료제 분야의 대형 경쟁사
- UCBCompetitor
중추신경계·희귀질환 치료제에서 경쟁
ETFs holding this stock
AdvisorShares Psychedelics ETF
Details →About NRX Pharmaceuticals
- What technical signals does NRX Pharmaceuticals (NRXP) have?
- NRX Pharmaceuticals current technical signals: no active technical signal.
- Is NRX Pharmaceuticals a cup-and-handle pattern?
- No. NRX Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for NRX Pharmaceuticals?
- Market cap: $80.08M. Trailing 12 months PER: -4.6×. Latest quarter PBR: -631.18×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about NRX Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.